Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Hypertension. 2019 Mar;73(3):630–639. doi: 10.1161/HYPERTENSIONAHA.118.12378

Figure 6:

Figure 6:

. (A&B) SS rats were injected with 15 mg/kg PP242 or vehicle and kidneys were harvested after 1 hr and 24 hr of treatment, respectively. Western blots of pAKTS473 and pS6S235/236 were normalized with total endogenous AKT and S6 proteins, respectively. (C) To determine inhibitory effect of PP242 on surrogate marker of SGK1 (pNDRG1T346/NDRG1), kidneys were excised 1 hr post-IP injection. Medullary tissue was used to asses pAKTT308, pAKTS473 and pNDRG1T346 as well as AKT, NDRG1 and GAPDH expression by Western blot analysis. In all panel graphs represent the fold change of pAKTS473/AKT or pS6S235/236/S6 or pNDRG1T346/NDRG1 or pAKTT308/AKT from vehicle in the cortex or medulla of these rats. Student’s t-test was used to compare PP242 and vehicle treatment.